FAAH2

Fatty-acid amide hydrolase 2 · Q6GMR7 · FAAH2 on Sugi Atlas →

569 patent compounds predicted against FAAH2, 477 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
Urb-597 Urb-597 (SCHEMBL93842) 1.00 1/20
SCHEMBL1471932 SCHEMBL1471932 1.00 1/20
SCHEMBL3183288 SCHEMBL3183288 1.00 1/20
SCHEMBL3193713 SCHEMBL3193713 1.00 1/20
SCHEMBL3203964 SCHEMBL3203964 1.00 1/20
Urb-597 Urb-597 (SCHEMBL29371698) 1.00 1/20
SCHEMBL3196450 SCHEMBL3196450 0.98 1/20
SCHEMBL14187855 SCHEMBL14187855 0.98 1/20
SCHEMBL17175654 SCHEMBL17175654 0.93 1/20
SCHEMBL3184217 SCHEMBL3184217 0.91 1/20
SCHEMBL4750537 SCHEMBL4750537 0.86 1/20
SCHEMBL712398 SCHEMBL712398 0.85 1/20
SCHEMBL10089400 SCHEMBL10089400 0.84 1/20
SCHEMBL710090 SCHEMBL710090 0.83 1/20
SCHEMBL710091 SCHEMBL710091 0.83 1/20
SCHEMBL710374 SCHEMBL710374 0.83 1/20
SCHEMBL710756 SCHEMBL710756 0.83 1/20
SCHEMBL719614 SCHEMBL719614 0.83 1/20
SCHEMBL720053 SCHEMBL720053 0.83 1/20
SCHEMBL14188106 SCHEMBL14188106 0.82 1/20

Clinical trials — most relevant to FAAH2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Investigating the Effects of Nabilone on Endocannabinoid Metabolism PHASE4COMPLETED
Treatment Strategies in CHS PHASE4COMPLETED
Efficacy of Ultra-micronized Palmitoylethanolamide (Um-PEA) in Geriatric Patients With Chronic Pain PHASE4COMPLETED
European Celecoxib Trial in Primary Breast Cancer PHASE3COMPLETED
Effect of Cannabinoid Agonist on Gastrointestinal and Colonic Motor Functions in Patients With Irritable Bowel Syndrome (IBS) PHASE2COMPLETED
Safety and Efficacy Study of PEA and Polydatin on Intestinal Inflammation and Visceral Hyperalgesia in IBS Patients PHASE2UNKNOWN
Analgesic Efficacy of Pre-Operative Dose of Palmitoylethanolamide in Patients Undergoing Total Knee Arthroplasty PHASE1/PHASE2NOT_YET_RECRUITING
Safety and Efficacy of a FAAH-Inhibitor to Treat Cannabis Withdrawal PHASE2COMPLETED
Palmitoylethanolamide for Chronic Inflammatory Pain Conditions PHASE2RECRUITING
Effect of Hemp-CBD on Patients With CIPN PHASE2UNKNOWN
Ibuprofen Versus Acetaminophen for Treatment of Mild Traumatic Brain Injury PHASE2WITHDRAWN
A Study Investigating the Bioavailability of CBD and THC in an Emulsion Product in a Healthy Population PHASE1COMPLETED
Safety, Tolerability, and Pharmacokinetics of Multiple Doses of Oral EC5026 in Healthy Subjects PHASE1COMPLETED
Topical Cannabidiol Cream and Post-exercise Recovery EARLY_PHASE1WITHDRAWN
Gene Expression of Endocannabinoid System in Episodic and Chronic Migraine Patients nanCOMPLETED
Concentration of Receptors With Affinity for Cannabidiol and Cannabinol and the Effect on Chronic Orofacial Pain of Muscle Origin nanENROLLING_BY_INVITATION
Prostaglandin and Cannabinoid Receptors in EoE nanCOMPLETED
Psychological and Biological Markers of Refractory Migraine nanUNKNOWN
Effects of Probiotics on Gut Microbiota, Endocannabinoid and Immune Activation and Symptoms of Fatigue in Dancers nanCOMPLETED
Biochemical Profiling of Migraine Patients nanRECRUITING
The Effect of Palmitylethanolamide on Central and Peripheral Sensitization After Heat-induced Hyperalgesia nanCOMPLETED
Effect of OMM on Anandamide Levels in Saliva nanCOMPLETED
Cytokine Production of Colonic Tissue From IBD Patients nanUNKNOWN
Production of Gut Microbiota-Derived Metabolites in Response to Different Fatty Acid Profiles nanCOMPLETED
Biomarker for Farber Disease (BioFarber) nanWITHDRAWN
The Severe Asthma Research Program III-Boston Clinical Site nanCOMPLETED
Observational STudy to Evaluate the EFfectiveness of OnLife® in Improving CIPN in Patients With Colon or Breast Cancer After End of Adj. Therapy nanCOMPLETED
Dose-response Effect of Pine Nut Oil as a Dual FFA1 and FFA4 Agonist on Glucose Tolerance in Healthy Humans. nanCOMPLETED
Gastric Bypass and Peripheral Activity of the Endocannabinoid System nanCOMPLETED
PGE2/IL-22 Pathway in Various Forms of Eczema nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a FAAH2 binder may also engage these)

ProteinNameSimilarity
Q6DH69 0.987 Q6DH69 →
Q05AM4 0.981 Q05AM4 →
Q90578 0.973 Q90578 →
O08914 0.973 O08914 →
P97612 0.972 P97612 →
FAAH Fatty-acid amide hydrolase 1 0.967 landscape →
F4KCL7 0.961 F4KCL7 →
Q9TUI8 0.961 Q9TUI8 →
Q8BX05 0.957 Q8BX05 →
O54695 0.956 O54695 →
Q6GM82 0.955 Q6GM82 →
Q08D86 0.955 Q08D86 →
Q3MHG1 0.955 Q3MHG1 →
Q5R514 0.954 Q5R514 →
Q8BGT5 0.954 Q8BGT5 →
Q68FH4 0.954 Q68FH4 →
Q01415 0.954 Q01415 →
O35704 0.953 O35704 →
Q9MUK5 0.953 Q9MUK5 →
D4A2H2 0.953 D4A2H2 →
Q9LVH5 0.953 Q9LVH5 →
Q99J47 0.952 Q99J47 →
Q5XIG6 0.952 Q5XIG6 →
Q5R9T5 0.952 Q5R9T5 →
Q60HD1 0.952 Q60HD1 →
P31754 0.952 P31754 →
Q0VFE7 0.952 Q0VFE7 →
Q6ZS86 0.951 Q6ZS86 →
Q9CZ42 0.951 Q9CZ42 →
Q2TAA5 0.951 Q2TAA5 →